Nisa Investment Advisors LLC Has $513,000 Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Nisa Investment Advisors LLC decreased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) by 37.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,681 shares of the company’s stock after selling 5,805 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $513,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC acquired a new stake in Prestige Consumer Healthcare during the 4th quarter valued at $26,000. Rockefeller Capital Management L.P. lifted its holdings in Prestige Consumer Healthcare by 54.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 843 shares of the company’s stock valued at $51,000 after purchasing an additional 297 shares during the last quarter. Point72 Hong Kong Ltd lifted its holdings in Prestige Consumer Healthcare by 1,705.4% during the 4th quarter. Point72 Hong Kong Ltd now owns 1,679 shares of the company’s stock valued at $102,000 after purchasing an additional 1,586 shares during the last quarter. Okabena Investment Services Inc. acquired a new stake in Prestige Consumer Healthcare during the 4th quarter valued at $114,000. Finally, Islay Capital Management LLC acquired a new stake in Prestige Consumer Healthcare during the 4th quarter valued at $129,000.

Prestige Consumer Healthcare Stock Down 0.4 %

Shares of NYSE PBH opened at $58.41 on Monday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.21 and a current ratio of 2.04. Prestige Consumer Healthcare Inc. has a 52 week low of $51.70 and a 52 week high of $63.83. The stock has a market capitalization of $2.92 billion, a P/E ratio of 14.46, a PEG ratio of 1.74 and a beta of 0.51. The stock’s fifty day moving average is $56.85 and its 200 day moving average is $56.57.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last issued its quarterly earnings results on Thursday, May 5th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Prestige Consumer Healthcare had a return on equity of 13.82% and a net margin of 18.90%. The company had revenue of $266.94 million for the quarter, compared to analysts’ expectations of $258.25 million. During the same quarter last year, the business earned $0.79 earnings per share. Prestige Consumer Healthcare’s revenue was up 12.3% on a year-over-year basis. Sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.19 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on PBH shares. Jefferies Financial Group raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the stock from $65.00 to $70.00 in a report on Tuesday, May 10th. Oppenheimer raised Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 target price for the company in a report on Monday, May 9th. Finally, StockNews.com started coverage on Prestige Consumer Healthcare in a report on Thursday, March 31st. They set a “buy” rating for the company. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average price target of $80.50.

Prestige Consumer Healthcare Profile

(Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

See Also

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.